Shin Nippon Biomedical Laboratories (SNBL) Acquires Satsuma Pharmaceuticals
Shin Nippon Biomedical Laboratories (SNBL) acquired Satsuma Pharmaceuticals for $220.0M. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Shin Nippon Biomedical Laboratories (SNBL)
- Acquired Company
- Satsuma Pharmaceuticals
- Price
- $220.0M
- Acquisition Type
- Acquisition
- Announced
- April 16, 2023
Canonical: https://fsome.com/acquisitions/shin-nippon-biomedical-laboratories-snbl-acquires-satsuma-pharmaceuticals-8084510 · For the full deal terms, timeline, and press references, please enable JavaScript.